Knowledge of MRNA COVID "VACCINES"
Dear Department of Health,
I would like to request that the public receive all of the information which the Australian Federal Government or any State/Territory Governments had regarding the MRNA COVID-19 "Vaccines" in the year 2021 at the time of the "vaccine" rollout, specifically on the subjects of:
-The known and potential side effects (Eg. Myocarditis, Infertility),
-Contamination of the contents of the shots with other substances (Eg. DNA),
-Whether or not these "vaccines" prevented infection or transmission
-Whether or not the "vaccines" in question remains in your body for any extended period of time (longer than two weeks)
-Whether or not any properties of or caused by the vaccines in question are passed down to offspring of the covid-19 "vaccinated".
This is a very important matter and serious follow-ups are required if any branches of Government had knowledge of negative or important factors and effects of these "vaccines" and still encouraged people to receive them and did not tell the citizens of the Commonwealth of Australia about these effects, or even lied about them (Eg. Saying the "vaccines" prevented transmission in advertismens when it is now known that there was NEVER any evidence of this whatsoever).
I would like to make it clear that I wish to receive a detailed report on ALL of the knowledge the Australian Government had on these topics at the time of the COVID-19 vaccine rollout.
Yours faithfully,
David Malcolm
Dear Mr Malcolm
Please find attached correspondence in relation to your Freedom of
Information request.
As outlined in the attached letter, pursuant to section 24AB(8) of the
Freedom of Information Act 1982, the processing time for your request has
been set aside to allow for the commencement of the request consultation
period.
During the consultation period, the FOI team (in collaboration with the
relevant line area) are available to assist you in revising the scope of
your request so that the practical refusal reason no longer exists, as is
required under the FOI Act. Our aim during the consultation period is to
assist you to define a revised scope which can then be formally submitted
so that processing of your request may continue, and a practical refusal
decision may be avoided.
To assist you further, you may also consider submitting a draft revised
scope to us for consideration during the request consultation period. We
will then liaise with the relevant TGA line area on your behalf and
provide you with advice as to whether your amended scope is now considered
reasonable to process.
The request consultation period currently expires on 8 May 2024.
Therefore, we seek your response prior to this date. We would be happy to
extend the consultation process under section 24AB(5) of the FOI Act
should the initial 14 day period not be sufficient to reach agreement.
Please note, once you formally submit a revised scope to us, the
processing clock will recommence and processing of your request will
continue. If the revised scope remains unreasonable to process, the
decision maker may decide to refuse your request under section 24 of the
FOI Act.
If you have any questions, please do not hesitate to contact the FOI Team.
Karen Bedford | Emily May | Tara Condon | Christina Bush | Lily Espinosa
Therapeutic Goods Administration
Australian Government Department of Health and Aged Care
Address: PO Box 100, Woden ACT, 2606, Australia
Email: [1][email address]
+ 61 2 6289 4630
Important: This transmission is intended only for the use of the addressee
and may contain confidential or legally privileged information. If you are
not the intended recipient, you are notified that any use or dissemination
of this communication is strictly prohibited. If you receive this
transmission in error please notify the author immediately and delete all
copies of this transmission.
"Important: This transmission is intended only for the use of the
addressee and may contain confidential or legally privileged information.
If you are not the intended recipient, you are notified that any use or
dissemination of this communication is strictly prohibited. If you
receive this transmission in error please notify the author immediately
and delete all copies of this transmission."
References
Visible links
1. mailto:[email address]